XML Feed for RxPG News   Add RxPG News Headlines to My Yahoo!   Javascript Syndication for RxPG News

Research Health World General
 
  Home
 
 Latest Research
 Cancer
 Psychiatry
 Genetics
 Surgery
 Aging
 Ophthalmology
 Gynaecology
 Neurosciences
 Pharmacology
 Cardiology
 Obstetrics
 Infectious Diseases
 Respiratory Medicine
 Pathology
 Endocrinology
  Diabetes
   NIDDM
   Insulin Resistance
 Immunology
 Nephrology
 Gastroenterology
 Biotechnology
 Radiology
 Dermatology
 Microbiology
 Haematology
 Dental
 ENT
 Environment
 Embryology
 Orthopedics
 Metabolism
 Anaethesia
 Paediatrics
 Public Health
 Urology
 Musculoskeletal
 Clinical Trials
 Physiology
 Biochemistry
 Cytology
 Traumatology
 Rheumatology
 
 Medical News
 Health
 Opinion
 Healthcare
 Professionals
 Launch
 Awards & Prizes
 
 Careers
 Medical
 Nursing
 Dental
 
 Special Topics
 Euthanasia
 Ethics
 Evolution
 Odd Medical News
 Feature
 
 World News
 Tsunami
 Epidemics
 Climate
 Business
 
 India
Search

Last Updated: Nov 18, 2006 - 12:32:53 PM

Diabetes Channel
subscribe to Diabetes newsletter

Latest Research : Endocrinology : Diabetes

   DISCUSS   |   EMAIL   |   PRINT
Gene therapy prevents onset of hyperglycemia in diabetes prone mice
Jun 3, 2006 - 9:50:00 AM, Reviewed by: Dr. Sanjukta Acharya

"We've shown it is now possible to efficiently insert genes into beta cells in a living organism, allowing us to analyze the effects that different gene products have on the progression of type 1 diabetes"

 
Using state-of-the-art gene therapy techniques, University of Pittsburgh investigators have successfully prevented the onset of elevated blood sugar, or hyperglycemia, in diabetes-prone mice by inserting a gene encoding for a cytokine -- a protein that stimulates or inhibits the proliferation or function of immune cells -- into their insulin-producing cells. According to the investigators, these findings, which are being presented at the American Society of Gene Therapy Annual Meeting in Baltimore, May 31 to June 4, have significant implications for the prevention of type 1 diabetes.

More than 700,000 Americans have type 1 diabetes, an autoimmune disorder in which the body errantly attacks the cells of the insulin-producing cells of the pancreas, causing chronic hyperglycemia and complications such as blindness, kidney failure, heart disease and nerve damage. Previously known as juvenile diabetes, type 1 diabetes is usually diagnosed at a very early age but is sometimes not diagnosed until the individual reaches adulthood.

In this study, the Pitt researchers used a gene-delivery vehicle known as an adeno-associated virus to insert genes for either of two cytokines, interleukin-4 (IL-4) or interleukin-10 (IL-10), into the insulin-producing beta cells of non-obese diabetic (NOD) mice. Following gene delivery, expression of IL-4 in beta cells prevented the onset of hyperglycemia in NOD mice, whereas beta cell expression of IL-10 accelerated the onset of hyperglycemia.

According to lead author Khaleel Rehman Khaja, Ph.D., senior research associate, department of molecular genetics and biochemistry, University of Pittsburgh School of Medicine, results from this animal study suggest that gene therapy is a viable method for preventing the onset of type 1 diabetes in genetically at-risk people.

"We know that the prevention of type 1 diabetes requires early intervention in the autoimmune process directed against beta cells of the pancreatic islets. Although the exact mechanism is still under investigation, we believe the protection we observed in our study is due to IL-4 stimulating an increase in regulatory T cells, which are known to suppress the activation of the immune system. However, the most important aspect of our study is that we've shown it is now possible to efficiently insert genes into beta cells in a living organism, allowing us to analyze the effects that different gene products have on the progression of type 1 diabetes," he explained.
 

- American Society of Gene Therapy Annual Meeting in Baltimore, May 31 to June 4
 

www.upmc.edu

 
Subscribe to Diabetes Newsletter
E-mail Address:

 

Others involved in this study include Zhong Wang, Ph.D., Xiao Xiao, Ph.D., and Paul D. Robbins, Ph.D., departments of molecular genetics and biochemistry and orthopaedic surgery, University of Pittsburgh School of Medicine.

Related Diabetes News

Diabetes is an independent predictor of acute organ failure and subsequent death
Insulin resistance in early teens may predict diabetes
Low-fat vegan diet rivals oral diabetes medications
Conjugated linoleic acids in dairy products targets diabetes
TrialNet - Can Type 1 diabetes be prevented?
Infections Link With diabetes
Netrins hold potential for treating diabetes
Coffee might reduce risk of type 2 diabetes
Race may be risk factor for insulin resistance
Impaired blood vessel responses seen in children of diabetics


For any corrections of factual information, to contact the editors or to send any medical news or health news press releases, use feedback form

Top of Page

 

© Copyright 2004 onwards by RxPG Medical Solutions Private Limited
Contact Us